Wedbush Trims IGM Biosciences (NASDAQ:IGMS) Target Price to $22.00
IGM Biosciences (NASDAQ:IGMS – Free Report) had its price target trimmed by Wedbush from $25.00 to $22.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has an outperform rating on the stock. Wedbush also issued estimates for IGM Biosciences’ Q3 2024 earnings at ($0.83) EPS, Q4 2024 earnings at […]
More Stories
PepsiCo (NASDAQ:PEP) PT Raised to $185.00
PepsiCo (NASDAQ:PEP – Free Report) had its target price raised by JPMorgan Chase & Co. from $182.00 to $185.00 in...
PepsiCo (NASDAQ:PEP) PT Raised to $185.00
PepsiCo (NASDAQ:PEP – Free Report) had its target price raised by JPMorgan Chase & Co. from $182.00 to $185.00 in...
PepsiCo (NASDAQ:PEP) PT Raised to $185.00
PepsiCo (NASDAQ:PEP – Free Report) had its target price raised by JPMorgan Chase & Co. from $182.00 to $185.00 in...
The Real State of the U.S. Economy: Unemployment Figures Twice as High Under Biden-Harris Administration
By Stephen Zogopoulos, USNN World News As the Biden-Harris administration continues to tout economic recovery and low unemployment rates, a...
The Real State of the U.S. Economy: Unemployment Figures Twice as High Under Biden-Harris Administration
By Stephen Zogopoulos, USNN World News As the Biden-Harris administration continues to tout economic recovery and low unemployment rates, a...
The Real State of the U.S. Economy: Unemployment Figures Twice as High Under Biden-Harris Administration
By Stephen Zogopoulos, USNN World News As the Biden-Harris administration continues to tout economic recovery and low unemployment rates, a...